In contrast, our data in the model of rUUO in C57Bl/6 suggest that CD4+ T cells or a subpopulation thereof (e.g., Th1 or Treg) may have a protective role in the early stages of kidney disease development; however, any such benefit is overcome in the later stages of disease. Here, CD4 is linked to kidney disorder.